Udvalget for Humanmedicinske Lægemidler (CHMP) konkluderede, at de gennemførte undersøgelser har vist, at RotaTeq beskytter mod rotavirus gastroenteritis, som forårsages af bestemte typer af virussen.
The Committee for Medicinal Products for Human Use (CHMP) concluded that the studies carried out had shown that RotaTeq protects against rotavirus gastroenteritis due to specific types of the virus.